McAdam LLC’s Adient ADNT Stock Holding History

McAdam LLC’s Portfolio ADNT Stock Details ADNT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-16	Closed	-$1K	–	69
2018 Q3	$1K	Hold	16	–	–	﹤0.01%	557
2018 Q2	$1K	Sell	16 -36	-69%	-$2.04K	﹤0.01%	527
2018 Q1	$3K	Buy	+52	New	+$3.47K	﹤0.01%	452

Other funds holding ADNT

DSA

Davis Selected Advisers Tucson, Arizona $23.3B AUM 26.95% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

BHG

Blue Harbour Group Greenwich, Connecticut $353M AUM 8.9% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return

LAM

Lyrical Asset Management New York $7.88B AUM 36.5% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

LCM

Lakewood Capital Management New York $1.94B AUM 9.49% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

LBA

Letko, Brosseau & Associates Montreal, Quebec, Canada $6.77B AUM 38.11% 1-Year Est. Return

McAdam LLC's ADNT Position: Q4 2018 in Review

McAdam LLC sold out of Adient (ADNT) in Q4 2018, closing a stake of 16 shares — an estimated $1K sold.

McAdam LLC first reported a position in ADNT in Q1 2018 and held it in 3 quarters. The position peaked at $3K in Q1 2018. 348 funds tracked by Wall St. Rank hold ADNT as of Q4 2018.

McAdam LLC reported no remaining Adient position as of Q4 2018 after selling out during the quarter.
McAdam LLC sold 16 Adient shares in Q4 2018, an estimated $1K.
McAdam LLC first reported a position in Adient in Q1 2018 and held it in 3 quarters.
McAdam LLC's Adient position peaked at $3K in Q1 2018.
348 funds tracked by Wall St. Rank held Adient as of Q4 2018.

Based on McAdam LLC's 13F filing for Q4 2018, filed 30 Jan 2019.